Stop using nowDrug recall · FDA · Published October 30, 2014
Baxter Recalls Heparin Sodium Injection Due to Low Potency
Baxter Healthcare recalls specific lots of Heparin Sodium in 0.9% Sodium Chloride Injection due to subpotent raw material. Check your lot numbers immediately.
Subpotent Drug: Heparin raw material was found to have low potency
Take action
Contact the company
📍Recalling firmBaxter Healthcare Corp.1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer
Baxter Healthcare Corporation is recalling Heparin Sodium in 0.9% Sodium Chloride Injection because the raw material was found to have low potency, making the drug subpotent. The recall affects 127,746 Viaflex Plus Containers distributed nationwide. These units were manufactured at the Jayuya, Puerto Rico facility and had an expiration date of February 29, 2016. Read more at govinfonow.com/recall/45642-baxter-healthcare-corp-recalls-heparin-sodium-in-0-9-sodium.
“Baxter Recalls Heparin Sodium Injection Due to Low Potency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45642-baxter-healthcare-corp-recalls-heparin-sodium-in-0-9-sodium. Based on FDA recall #D-0276-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0276-2015%22&limit=1).
The FDA announced on Oct. 30, 2014, that Baxter Healthcare Corp. recalled Heparin Sodium in 0.9% Sodium Chloride Injection due to subpotent drug concerns. The agency stated the recall was voluntary and initiated by the firm.
How to tell if you have it
Brand: Baxter Healthcare
Product: Heparin Sodium Injection
NDC: 0338-0431-03
Lot codes: N003061, N003079, and N003087
Expiration date: 2/29/2016
Quantity: 127,746 Viaflex Plus Containers
The hazard
The recall addresses a subpotent drug hazard where Heparin raw material was found to have low potency. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Baxter Healthcare Corp. has 34 other recalls on record since Sept. 21, 2012. Other recent recalls of similar products include the Baxter Amia Dialysis Set Recall (Sept. 1, 2017), the Baxter Recalls Brevibloc Injection Due to Discoloration (April 12, 2016), and the Baxter Recalls Sodium Chloride Irrigation Due to Insect Contamination (Feb. 5, 2016). Additional recent recalls of similar products include the Baxter Famotidine Injection Recall (Aug. 6, 2026), the Baxter Vasopressin Injection Recall (Aug. 6, 2026), and the Baxter Pantoprazole Sodium Injection Recall (Aug. 6, 2026).
How to tell if you have this one
Look for Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container. Check the NDC number (0338-0431-03) and verify if the lot number is N003061, N003079, or N003087.
Brand
Baxter Healthcare
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop using the product
Do not use any Heparin Sodium in 0.9% Sodium Chloride Injection from the recalled lots due to the risk of subpotency.
Check lot numbers
Verify if your unit has lot numbers N003061, N003079, or N003087 and an expiration date of 2/29/2016.
Contact healthcare provider
Consult your doctor or pharmacist for guidance on alternative treatment if you have used or possess the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 23 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0276-2015 (October 30, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0276-2015 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.